Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 899

1.

Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer?

Zöller M, Matzku S.

Arch Immunol Ther Exp (Warsz). 2002;50(3):197-224. Review.

PMID:
12098935
3.
5.

Specific immunotherapy of cancer in elderly patients.

Matzku S, Zöller M.

Drugs Aging. 2001;18(9):639-64. Review.

PMID:
11599633
7.

Non-myeloablative stem cell transplantation for the treatment of cancer and life-threatening non-malignant disorders; past accomplishments and future goals.

Slavin S, Aker M, Shapira MY, Panigrahi S, Gabriel C, Or R.

Transfus Apher Sci. 2002 Oct;27(2):159-66. Review.

PMID:
12350051
9.
10.

Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimeras.

Luznik L, Slansky JE, Jalla S, Borrello I, Levitsky HI, Pardoll DM, Fuchs EJ.

Blood. 2003 Feb 15;101(4):1645-52. Epub 2002 Oct 24.

11.

Allogeneic bone marrow transplantation: relation between chimaerism and immunity.

Vossen J.

Verh K Acad Geneeskd Belg. 1998;60(2):111-43; discussion 143-5. Review.

PMID:
9703764
12.

Non-myeloablative stem cell transplantation and donor lymphocyte infusion for the treatment of cancer and life-threatening non-malignant disorders.

Slavin S, Nagler A, Aker M, Shapira MY, Cividalli G, Or R.

Rev Clin Exp Hematol. 2001 Jun;5(2):135-46. Review.

PMID:
11486652
13.

[Allogeneic hematopoietic stem cell transplantation for solid tumors in the United States: a review].

Cheng YC, Ueno NT.

Nihon Rinsho. 2003 Sep;61(9):1619-34. Review. Japanese.

PMID:
14515734
14.

Targeting the immune system in cancer.

Chaudhuri D, Suriano R, Mittelman A, Tiwari RK.

Curr Pharm Biotechnol. 2009 Feb;10(2):166-84. Review.

PMID:
19199949
15.
16.

Nonmyeloablative stem cell transplantation for the treatment of cancer and life-threatening nonmalignant disorders: past accomplishments and future goals.

Slavin S, Or R, Aker M, Shapira MY, Panigrahi S, Symeonidis A, Cividalli G, Nagler A.

Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S79-84. Review.

PMID:
11587373
17.
18.

Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.

Slavin S, Aker M, Shapira MY, Resnick I, Bitan M, Or R.

Clin Transpl. 2003:275-82. Review.

PMID:
15387119
19.

Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.

Talmadge JE.

Int Immunopharmacol. 2003 Aug;3(8):1121-43. Review.

PMID:
12860168
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk